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Epidermal b-catenin activation remodels the
dermis via paracrine signalling to distinct
ﬁbroblast lineages
Beate M. Lichtenberger1,2, Maria Mastrogiannaki1 & Fiona M. Watt1
Sustained epidermal Wnt/b-catenin signalling expands the stem cell compartment and
induces ectopic hair follicles (EFs). This is accompanied by extensive ﬁbroblast proliferation
and extracellular matrix (ECM) remodelling in the underlying dermis. Here we show that
epidermal Hedgehog (Hh) and Transforming growth factor-beta (TGF-b) signalling mediate
the dermal changes. Pharmacological inhibition or genetic deletion of these pathways
prevents b-catenin-induced dermal reprogramming and EF formation. Epidermal Shh
stimulates proliferation of the papillary ﬁbroblast lineage, whereas TGF-b2 controls
proliferation, differentiation and ECM production by reticular ﬁbroblasts. Hh inhibitors do not
affect TGF-b target gene expression in reticular ﬁbroblasts, and TGF-b inhibition does not
prevent Hh target gene induction in papillary ﬁbroblasts. However, when Hh signalling
is inhibited the reticular dermis does not respond to epidermal b-catenin activation.
We conclude that the dermal response to epidermal Wnt/b-catenin signalling depends on
distinct ﬁbroblast lineages responding to different paracrine signals.
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W
nt signalling acts via both cell autonomous and
non-cell autonomous mechanisms to regulate skin
development and homeostasis1. One experimental
model that has been used extensively to study the effects of
Wnt activation in adult mouse skin is the K14DNb-cateninER
transgenic mouse2. In this model, topical application of 4-
hydroxy-tamoxifen (4OHT) leads to expression of N-terminally
truncated, constitutively active b-catenin in all epidermal cells
that express keratin 14 (K14), including stem cells in different
epidermal locations3. A single dose of 4OHT is sufﬁcient to
induce hair follicles (HFs) in the resting (telogen) phase of the
hair growth cycle to enter anagen (growth phase). Sustained Wnt/
b-catenin signalling in adult epidermis via repeated doses of
4OHT expands the stem cell compartment and drives cell fate
changes, such that cells of the interfollicular epidermis and
sebaceous gland form ectopic HFs (EFs)2,4,5.
Epidermal activation of b-catenin not only elicits profound
changes within the epidermis itself, but also causes changes in the
underlying connective tissue, characterized by increased ﬁbroblast
proliferation and extensive remodelling of the dermal extra-
cellular matrix (ECM)6. Recently, the ﬁbroblasts of the upper,
papillary, dermis have been shown to originate from a different
lineage to those of the lower, reticular dermis and dermal
adipocytes7. The papillary lineage is required for HF formation in
skin reconstitution assays, whereas the reticular lineage produces
the bulk of the ECM and is responsible for the ﬁrst wave of
dermal repair following a full thickness wound. Epidermal Wnt
activation in K14DNb-cateninER mice leads to an increase in the
abundance of both papillary and reticular lineages and as a result
new HFs form in the epidermal wound bed4,7.
In the present study, we set out to identify the signalling
mechanisms by which epidermal Wnt activation remodels the
dermis and to determine whether the papillary and reticular
dermal ﬁbroblasts respond to the same or different signals. We
ﬁnd that on Wnt/b-catenin activation, the epidermis expresses
Sonic hedgehog (Shh), which stimulates proliferation and ECM
remodelling by the papillary dermis, whereas the reticular dermis
responds to epidermal Transforming growth factor (TGF)-b.
These ﬁndings are of particular interest, given the many different
epithelial tumours in which there is inappropriate activation of
Wnt signalling accompanied by changes in the underlying
connective tissue8–10.
Results
Epidermal b-catenin causes intrinsic ﬁbroblast changes. To
address whether the stimulation of ﬁbroblast proliferation in
response to epidermal Wnt/b-catenin activation is a cell intrinsic
effect or a response to changes in the dermal ECM, we developed
a dermal reconstitution assay. The epidermis was enzymatically
removed from skin biopsies of neonatal (P2) or adult (telogen;
resting phase of the hair growth cycle) back skin and the dermis
was de-vitalized through repeated freeze/thaw cycles (Fig. 1a).
The resulting de-epidermized dermis (DED) was placed on a cell
culture insert, seeded with ﬁbroblasts isolated directly from P2
skin and cultured for 2–3 weeks. By 2 weeks, the ﬁbroblasts had
colonized the full thickness of the dermis, as visualized by
labelling for the pan-ﬁbroblast marker, Platelet-derived growth
factor receptor alpha (Pdgfra) (Fig. 1b,c). Fibroblasts isolated
from neonatal skin expanded more extensively in neonatal than
adult telogen DED at all three seeding densities and both time
points tested (Fig. 1d), demonstrating that the dermal ECM had
an impact on ﬁbroblast proliferation.
We next examined the effect of epidermal Wnt/b-catenin
activation by applying 4OHT to the back skin of telogen
K14DNb-cateninER mice2 to induce EFs. We then compared
the proliferation of ﬁbroblasts from untreated telogen skin,
wild-type P2 skin and skin containing EFs (Fig. 1e). Telogen
ﬁbroblasts showed limited proliferation in either P2 or telogen
DEDs. Fibroblasts isolated from the skin with EFs were more
proliferative than telogen ﬁbroblasts and, like P2 ﬁbroblasts,
proliferated more extensively in P2 DEDs than telogen DEDs
(Fig. 1e,f). This was also the case for ﬁbroblasts cultured on tissue
culture plastic (Fig. 1g). In contrast, the proportion of apoptotic
ﬁbroblasts did not differ signiﬁcantly between wild-type P2, adult
telogen and anagen skin or 4OHT-treated K14DNb-cateninER
skin (Fig. 1h,i). We conclude that ﬁbroblast proliferation is
inﬂuenced both by the dermal ECM (Fig. 1d,e) and by cell-
intrinsic changes resulting from postnatal age and epidermal
Wnt-activation (Fig. 1e–g).
Sequential induction of epidermal growth factors (GFs). To
identify candidate epidermal secreted factors that mediate the
dermal changes, we analysed published microarray data from
neonatal, telogen and anagen (growth phase of hair cycle) epi-
dermis, and epidermis that had formed EF in response to b-
catenin activation (three biological replicates per condition)6.
Secreted GFs found to be upregulated in neonatal, anagen and EF
epidermis but not telogen epidermis included Shh,
TGF-b2, Fibroblast growth factors 2 (FGF2) and 5 (FGF5)
(Fig. 2a). Quantitative reverse transcription–PCR (qRT–PCR)
conﬁrmed that Shh, TGF-b2 and FGF2 were highly expressed in
neonatal and EF epidermal cells compared with keratinocytes
from telogen skin (Fig. 2b). Expression of Shh, FGF2 and TGF-b2
was higher in P2 and EF epidermis than in anagen epidermis. In
contrast, FGF5 expression was lower in EF keratinocytes than the
other keratinocyte populations (Fig. 2b).
To examine the kinetics of GF signalling in vivo, we treated
K14DNb-cateninER PDGFRaH2BeGFP (expressing eGFP in
nuclei of all ﬁbroblasts)6 double transgenic mice with 4OHT
(or vehicle) once or every other day for up to a total of seven
applications. Twenty-four hours after the last treatment, the
epidermis was separated from the dermis. Basal layer
keratinocytes were ﬂow-sorted from the epidermis on the basis
of Integrin a6 (ITGA6) expression, and total dermal ﬁbroblasts
on the basis of expression of PDGFRaH2BeGFP. As reported
previously2, two doses of 4OHT were sufﬁcient to induce anagen,
whereas after ﬁve treatments there was pronounced EF formation
(Supplementary Fig. 1). Activated (non-phosphorylated) b-
catenin was detected in all transgene-positive regions of the
epidermis following 4OHT treatment (Supplementary Fig. 1).
QRT–PCR analysis of mRNA from ﬂow-sorted epidermal cells
showed that Shh expression peaked after three 4OHT treatments,
whereas TGF-b2 and FGF2 levels rose later (Fig. 2c). Consistent
with those kinetics, the Hh target genes Gli1, Gli2 and Patched 1
(Ptch1) were maximally expressed in ﬁbroblasts after three 4OHT
treatments, whereas levels of TGF-b and FGF target genes—Pdgfb
and Sprouty, respectively—increased after four treatments
(Fig. 2d).
Based on previous reports11–14, we predicted that the effects of
Shh and FGF2 would be to stimulate ﬁbroblast proliferation,
whereas TGF-b2 should inhibit proliferation and promote
ECM remodelling. Treatment of adult ﬁbroblasts with FGF2
and Shh induced proliferation in culture, whereas, as reported
previously15, TGF-b2 was inhibitory (Fig. 2e). Accordingly, the
FGFR inhibitor PD173074 (Tocris) and the Hh/Smoothened
inhibitor IPI4182 (ref. 16; Inﬁnity Pharmaceuticals; compound
32) blocked ﬁbroblast proliferation, whereas two TGF-b
inhibitors (RepSox, Sigma Aldrich; and SB431542, Tocris)
stimulated proliferation (Fig. 2e). In cultured ﬁbroblasts,
TGF-b2 and FGF2 signiﬁcantly reduced expression levels of a
range of collagen genes and also of lysyl oxidase (Lox), which
cross-links collagen and elastin17, and the hyaluronidase Mgea5
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(Fig. 2f). In contrast, Shh did not affect the expression of
collagens and ECM-modifying enzymes (Fig. 2f). These results
suggest that the increase in epidermal Shh and FGF2 expression
upon b-catenin activation drives the increase in ﬁbroblast
proliferation, whereas the increases in TGF-b2 and FGF2
mediate the changes in ECM.
Effects of GF inhibition. To examine the roles of the candidate
secreted factors in vivo, K14DNb-cateninER PDGFRaH2BeGFP
double transgenic mice and PDGFRaH2BeGFP control
littermates were treated with PD173074, RepSox or IPI4182. We
compared telogen mice (4OHT-treated PDGFRaH2BeGFP single
transgenics) with K14DNb-cateninER PDGFRaH2BeGFP double
transgenic mice treated with 4OHT to induce ectopic follicle
formation for 2 weeks (Fig. 2g).
Haematoxylin and eosin (H&E) staining revealed that all three
inhibitors interfered with the epidermal and dermal responses to
b-catenin activation. The FGFR inhibitor had the mildest effect:
HF still entered anagen and formed EFs, but follicle length was
reduced (Fig. 2h; n¼ 8). In addition, telogen skin treated with
the FGFR inhibitor displayed epidermal hyperproliferation but
no changes in the dermis (Fig. 2h; n¼ 8). In the presence of
RepSox, anagen and EF formation was largely inhibited (Fig. 2i;
n¼ 10–11). RepSox treatment also resulted in an increased
ﬁbroblast density and reduction in the skin adipocyte layer,
whether applied to wild-type telogen or K14DNb-cateninER
transgenic 4OHT-treated skin (Fig. 2i; n¼ 10–11 per condition).
The Hh inhibitor had no effect on telogen skin (n¼ 10), but the
strongest effect of the three inhibitors on K14DNb-cateninER
transgenic 4OHT-treated skin, resulting in complete inhibition
of Wnt-mediated anagen and EF induction (9 out of 12 mice;
Fig. 2j).
Since the effects of Hh and TGF-b inhibition were the most
pronounced, we examined the changes in the dermis in more
detail. As previously reported7,18 there was an increase in the
number of ﬁbroblasts in all regions of the dermis in response to
epidermal Wnt/b-catenin activation (Figs 2h–j and 3a,b) and an
increase in the thickness of the adipocyte layer18 (Fig. 2h–j).
5-Ethynyl-20-deoxyuridine (EdU) labelling demonstrated an
increase in ﬁbroblast proliferation, which was maximal after three
doses of 4OHT (Fig. 3c). Treatment with IPI4182 signiﬁcantly
reduced the proliferative response to 4OHT (Fig. 3d). In contrast,
RepSox treatment increased ﬁbroblast proliferation in telogen skin
(Fig. 3e), consistent with the increased ﬁbroblast density observed
in H&E-stained RepSox-treated telogen skin sections (Fig. 2i).
RepSox treatment did not, however, have a statistically signiﬁcant
effect on ﬁbroblast proliferation in 4OHT-treated K14DNb-
cateninER transgenic skin (Fig. 3e).
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repopulating de-epidermized dermis (DED) from murine skin. (b,c) Sections of P2 DEDs after 2 weeks of culture stained with antibodies to PDGFRa
(green) and collagen 3 (red), counterstained with 4,6-diamidino-2-phenylindole (DAPI; blue). DEDs were unseeded (b) or seeded with 2 105 neonatal
ﬁbroblasts (c). Scale bars, 50mm (d) Quantiﬁcation of ﬁbroblasts isolated from 2-day-old mice and seeded onto P2 or adult telogen (TELO) DEDs.
Fibroblasts were cultured in DMEM/10% FCS for 2–3 weeks. *Pr0.05; **Pr0.005; ***Pr0.0005 between cells seeded on neonatal or adult DEDs;
#Pr0.05; ##Pr0.005; compared with 1 105 seeded ﬁbroblasts; by a one-way analysis of variance (ANOVA). (e) Quantiﬁcation of ﬁbroblasts isolated
from neonatal (P2), telogen skin (Telo) or skin containing ectopic follicles (EF). (e) *Pr0.05; between cells seeded on neonatal or adult DEDs; #Pr0.05;
##Pr0.005; compared with telogen; by a one-way ANOVA. MF, microscopic ﬁeld. (d,e) Data show means±s.e.m. of triplicate samples in a representative
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To investigate whether the inhibitors affected epidermal
b-catenin-induced dermal ECM remodelling, we performed
Herovici staining (Fig. 3f,g). This stain labels mature ﬁbrillar
collagen pink and immature collagen blue19. Both IPI4182-
treated and untreated telogen dermis had a preponderance
of mature collagen, whereas untreated dermis of mice with
epidermal b-catenin activation had a high proportion of
immature collagen, as reported previously6 (Fig. 3f). Skin in
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which EF formation was blocked with IPI4182 was similar to
telogen skin but displayed patches of immature collagen in the
lower dermis (Fig. 3f). In contrast, inhibition of TGF-b in
4OHT-treated K14DNb-cateninER skin resulted in extensive
ECM remodelling as shown by intense blue Herovici staining
(Fig. 3g).
Conﬁrming the histological analysis, the effects of RepSox on
expression of several collagen genes, elastin and ECM-modifying
enzymes were more pronounced than those of IPI4182 (Fig. 3h,i).
However, Collagen type 11, which is upregulated in ﬁbroblasts in
close proximity to EFs6, was inhibited by IPI4182, RepSox and the
FGFR inhibitor PD173074 (Fig. 3h,i and Supplementary Fig. 2a).
Immunoﬂuorescent staining for Col3a1, Col11a1 and Elastin
(Supplementary Fig. 2b–e) was consistent with the Herovici
labelling and qRT–PCR data (Fig. 3f–i).
In addition to examining the composition of the dermal ECM,
we determined the thickness of the skin adipocyte layer by
labelling mature adipocytes with anti-caveolin or Lipidtox
(Fig. 3j–l). Treatment of telogen skin with the Hh inhibitor
did not affect the thickness of the skin adipocyte layer,
but prevented the increase in adipose layer thickness that
normally occurs on epidermal b-catenin activation (Fig. 3k). In
contrast, RepSox signiﬁcantly reduced the number of mature
adipocytes in telogen and 4OHT-treated K14DNb-cateninER skin
(Fig. 3j,l).
To conﬁrm that the inhibitors were indeed targeting the
appropriate pathways, we performed qRT–PCR of ﬁbroblasts
isolated directly from mouse skin (Supplementary Fig. 3).
Comparison of IPI4182- and vehicle-treated back skin showed
that expression of the Hh target genes Gli1, Gli2 and Ptch1 was
signiﬁcantly downregulated when there was a complete block in
EF formation. Moreover, in those mice that had only partial
inhibition of the b-catenin-induced phenotype (3 out of 12 mice)
there was no reduction in target gene expression (Supplementary
Fig. 3a). Levels of TGF-b (Id1, Id2, Myc, Cxcl12) and FGF
(Sprouty) target genes were not affected by the Hh inhibitor
(Supplementary Fig. 3b). Gli1, Gli2, Ptch1 and Shh expression
levels were not affected in epidermal cells isolated from inhibitor-
treated skin (Supplementary Fig. 3c), indicating that inhibition of
EF formation was due to an effect on ﬁbroblasts rather than
epidermal cells.
RepSox reduced expression of the TGF-b target gene Id1,
whereas expression of Hh and FGF target genes was not affected
(Supplementary Fig. 3d). The FGFR inhibitor enhanced
expression of Hh target genes in telogen skin and of Id1 in
4OHT-treated K14DNb-cateninER skin (Supplementary Fig. 3e).
In accordance with the mild effect on EF formation, the FGFR
inhibitor did not effectively inhibit expression of the FGF target
gene Sprouty, which was also not signiﬁcantly affected by RepSox
and IPI4182 (Supplementary Fig. 3b,d,e). These data suggest
that there is no cross-talk between the Hh and TGF-b
signalling pathways but that FGFR signalling affects both
pathways.
Effects of GF inhibition on ﬁbroblast subpopulations. To
examine the effects of epidermal b-catenin activation on papillary
and reticular dermal ﬁbroblasts, we sought to identify markers
that would allow us to distinguish them. We have previously
shown that at E16.5 dermal ﬁbroblasts that will give rise to the
upper dermal lineages (papillary ﬁbroblasts, including cells of the
dermal sheath (DS), dermal papilla (DP) and arrector pili muscle)
express leucine-rich repeats and immunoglobulin-like domains
protein 1 (Lrig1), whereas cells that will give rise to the
lower dermis and adipocyte layer express Delta-like 1 (Dlk1)7.
Lineage tracing using Dlk1-CreER7 or Lrig1-GFP-IRES-CreER20
(Lrig1CreER) Rosa-CAG-loxP-stop-loxP21 (hereafter LSL-tdTomato
mice, in which tdTomato is expressed when the stop codon is
removed via Cre-mediated recombination) mice injected with
tamoxifen at E16.5 conﬁrmed that in adult telogen mice (8 weeks)
the Dlk1 lineage was conﬁned to the lower dermis (Fig. 4a,b). Dlk1
protein is not expressed in postnatal ﬁbroblasts7, but Sca1 can be
used as a positive marker of lower dermal ﬁbroblasts, including
adipocytes7.
When Lrig1þ cells are marked with a low labelling efﬁciency
at E16.5, the majority of postnatal tdTomatoþ cells are in the
arrector pili muscle (APM) and DP7. However, more efﬁcient
induction of Lrig1CreER at E16.5 results in more extensive
labelling of dermal ﬁbroblasts. In addition to accumulation of
labelled cells in the dermal sheath, there was also labelling in the
reticular layer (Fig. 4c–e), and we detected occasional
tdTomatoþ /Sca1þ cells in the adipocyte layer. When
Lrig1CreER x LSL-tdTomato mice received multiple applications
of 4OHT, beginning at 8 weeks, the same distribution of labelled
ﬁbroblasts is found (Fig. 4f,g). Induction of ectopic follicles in
4OHT-treated K14DNb-cateninER skin resulted in a marked
increase in Lrig1þ ﬁbroblasts, with large numbers conﬁned to
the dermal sheath (Fig. 4h,i), whether detected by antibody
labelling (Fig. 4i) or 4OHT-mediated tdTomato labelling
(Fig. 4f,h).
We also examined the expression of CD26 (dipeptidyl
peptidase-4), which is restricted to papillary ﬁbroblasts and DP
cells in neonatal skin, but expressed by the majority of reticular
ﬁbroblasts in adult skin7,22,23 (Supplementary Fig. 4a,b). DP
cells are CD26þ in adult telogen but not anagen follicles
(Supplementary Fig. 4a). Flow cytometric analysis of adult skin
ﬁbroblasts revealed that in telogen the majority of ﬁbroblasts
(75–85%) were Sca1þ /CD26þ (Supplementary Fig. 4b) and
only a few cells were Lrig1þ (Fig. 4j). In contrast, anagen skin
Figure 2 | Pharmacological inhibition of FGF, TGF-b or Hh signalling impairs ectopic follicle (EF) formation in vivo. (a) Heat map (blue: low expression;
red: high expression) showing differential expression of growth factors in epidermis from neonatal, adult telogen (resting phase), anagen (active phase) and
reprogrammed (EF) skin. (b) Relative expression of the indicated growth factors in ﬂow-sorted epidermal cells measured by qRT–PCR. Data represent
mean±s.e.m. (n¼ 3–4). *Pr0.05; **Pr0.005; compared to telogen; #Pr0.05; ##Pr0.005; compared to anagen; yPr0.05; compared to P2; by a one-
way analysis of variance (ANOVA). c,d) Relative expression of growth factors in epidermal cells (c) and growth factor target genes in ﬁbroblasts (d)
isolated from K14DNb-cateninER transgenic mice treated seven times with vehicle alone (0x) or with 4OHT once or up to seven times. Data represent
mean±s.e.m. (n¼ 2). *Pr0.05; **Pr0.005; by Student’s T test. (e) Percentage of proliferating (EdUþ ) ﬁbroblasts 24 or 48 h after treatment with the
indicated growth factors or inhibitors. Green and red dotted lines represent the mean percentage of vehicle-treated cells after 24 h (red) and 48 h (green).
Cells were pulsed with EdU for 2 h. Cells were pooled from three technical replicates and the results are representative of n¼ 3 independent experiments.
(f) Bar graphs showing relative expression of the indicated genes in ﬁbroblasts isolated from adult skin and treated with Shh, TGF-b2, FGF2 or vehicle
in vitro. Data represent mean±s.e.m. (n¼ 3). *Pr0.05; **Pr0.005 by a one-way analysis of variance. (g) Treatment scheme. Topical application of 4OHT
induces Wnt/b-catenin activation in the epidermis of K14DNb-cateninER transgenic mice. Inhibitors were applied by subcutaneous injection (RepSox,
PD173074) or oral gavage (IPI4182) every other day. (h–j) Inhibition of FGF (h), TGF-b (i) Hh (j) signalling impairs or blocks induction of anagen and EFs in
K14DNb-cateninER transgenic mice. Representative haematoxylin and eosin stainings are shown. AD, adipocytes; ANA, anagen hair follicle; HF, hair follicle;
RD, reticular dermis. Scale bars, 200mm.
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Figure 3 | Effects of pharmacological Hh and TGF-b inhibitors on ﬁbroblast proliferation, ECM remodelling and adipogenesis.
(a,b) Immunoﬂuorescent staining of skin sections from telogen and reprogrammed skin from K14DNb-cateninER/ PDGFRaH2BeGFP double transgenic
mice showing an increase in dermal ﬁbroblasts upon epidermal Wnt/b-catenin activation. Keratin 14 is expressed in epidermal cells. All ﬁbroblasts
express H2BeGFP in their nuclei. Nuclei were detected with 4,6-diamidino-2-phenylindole (DAPI). (c–e) Quantiﬁcation of proliferating ﬁbroblasts in
K14DNb-cateninER/ PDGFRaH2BeGFP double transgenic mice treated with up to six doses of 4OHT (c) or treated with Hh (d) and TGF-b inhibitors (e).
Quantiﬁcation was performed by FACS (c,e) or in immunolabelled skin sections (d). Mice were injected with EdU 3 (c,e) or 4 h (d) before tissue collection.
Data represent mean±s.e.m. (n¼ 3–4). *Pr0.05, inhibitor-treated compared with vehicle-treated mice; #Pr0.05, EF skin compared with telogen skin, by
a one-way analysis of variance (ANOVA). (f,g) Herovici staining of skin sections from telogen and reprogrammed (EF) skin treated with Hh (f) or TGF-b
inhibitors (g). Immature collagen ﬁbres appear blue, whereas mature collagen is stained pink. Red box highlights a patch of immature collagen in the lower
dermis (f). (h,i) Relative expression of the indicated genes in ﬁbroblasts isolated from telogen and reprogrammed (EF) skin treated with IPI4182, RepSox or
vehicle. Data represent mean±s.e.m. (n¼4–5). (j) Number of adipocytes per microscopic ﬁeld (MF) quantiﬁed in H&E-stained sections. Data represent
mean±s.e.m. (n¼ 3). (h–j) *Pr0.05; **Pr0.005, inhibitor-treated compared with vehicle-treated mice; #Pr0.05, ##Pr0.005 compared with telogen
skin by a one-way ANOVA. (k,l) Immunoﬂuorescent staining of skin sections with antibodies to Caveolin and K14 or Lipidtox, counterstained with DAPI.
Scale bars in a,b,f,g,k and l represent 200mm.
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harboured a small percentage of Sca1þ /CD26þ cells, whereas
almost 50% of cells were Lrig1þ /Sca1 (Fig. 4k). Anagen skin
also contained a large number of Sca1 /CD26 ﬁbroblasts,
which included DP cells expressing CD133 (ref. 24; 20–25%) and
Lrig1þ cells (45–60%; Supplementary Fig. 4b).
Induction of ectopic follicles in 4OHT-treated K14DNb-
cateninER skin resulted in a further increase in Lrig1þ cells
(55–70%) and Sca1 /CD26 cells compared with anagen
skin, with most of the Sca1 /CD26 cells expressing Lrig1
or CD133, and o25% Sca1þ ﬁbroblasts (Fig. 4l,p and
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Supplementary Fig. 4d). Although both Lrig1þ and Sca1þ
ﬁbroblasts proliferated in response to multiple applications of
4OHT (EdUþ ; Fig. 4m,n), the ratio of Lrig1þ to Sca1þ
ﬁbroblasts increased dramatically (from 0.19 to 2.6; Fig. 4o).
The Hh inhibitor IPI4182 blocked the b-catenin-induced
increase in Lrig1þ ﬁbroblasts (Fig. 4p,r) and therefore the
increase in Sca1 /CD26 cells. As a result, the proportion of
Sca1þ ﬁbroblasts was restored to the level found in telogen skin
(Fig. 4q). RepSox treatment had little effect on the proportion of
Lrig1þ and Sca1þ ﬁbroblasts in telogen skin but reduced the
proportion of Lrig1þ (and also Sca1 /CD26 ) ﬁbroblasts and
increased the proportion of Sca1þ ﬁbroblasts on activation of
b-catenin (Fig. 4s–u). The reduction in mature adipocytes
on RepSox treatment (Fig. 3j) correlated with an increase in
Sca1þ /CD24þ pre-adipocytes (Fig. 4s,v).
These results show that although blocking either Hh or TGF-b
inhibits b-catenin-induced EF formation, the inhibitors act
on different ﬁbroblast subpopulations. Hh inhibition primarily
affects Lrig1þ ﬁbroblasts, whereas TGF-b inhibition exerts its
effect on lower dermal ﬁbroblasts and pre-adipocytes.
Smoothened deletion in ﬁbroblasts blocks dermal responses.
Hh signalling has been shown to be important for HF
morphogenesis and HF cycling25 and epidermal deletion of
the Hh effector gene Smoothened results in loss of HFs and
hyperproliferation of the interfollicular epidermis (Supplementary
Fig. 5a,b). To conﬁrm that the effects on EF formation of
treatment with the Hh inhibitor IPI4182 were indeed due to a
response of the ﬁbroblasts and not the epidermal cells, we crossed
our mouse model to conditional Smoothened mice (Smof/f)26 and
a Dermo1Cre (B6.129X1-Twist2tm1.1(cre)Dor/J)27 transgenic line,
enabling us to delete Smoothened speciﬁcally in ﬁbroblasts
(Supplementary Fig. 5c–e). Deletion of both Smoothened
alleles by this Cre line was embryonic lethal, but heterozygous
mice exhibited a normal lifespan. The heterozygous mutants
had signiﬁcantly fewer HF compared with wild-type skin
(83.39%±0.03%; n¼ 12; P¼ 0.0011) and entry into the anagen
phase of the hair growth cycle became desynchronized after the
ﬁrst postnatal hair cycle.
Deletion of a single Smoothened allele (SmoDDermo/þ mice)
signiﬁcantly reduced EF formation (Fig. 5a). SmoDDermo/þ skin
harboured fewer ﬁbroblasts throughout the papillary and reticular
dermis and in the dermal sheath (Fig. 5b,c and Supplementary
Fig. 5f), and displayed a shift towards the telogen phenotype in
the proportions of Lrig1þ , Sca1þ and Sca1þ /CD24þ
ﬁbroblasts (Fig. 5d-g), with fewer Lrig1þ ﬁbroblasts than EF
skin. In K14DNb-cateninER SmoDDermo/þ mice, the number
of Lrig1þ ﬁbroblasts accumulating around HF after three
4OHT treatments was much lower than the number in
K14DNb-cateninER Smof/f mice (Supplementary Fig. 5g, h).
Although the number of pre-adipocytes was not affected by Smo
deletion (Fig. 5g), K14DNb-cateninER SmoDDermo/þ skin
harboured fewer mature adipocytes (Fig. 5h and Supplementary
Fig. 4i), and ECM remodelling was reduced in K14DNb-
cateninER SmoDDermo/þ mice (Fig. 5i). The expression of
collagens was also altered compared with telogen skin as assessed
by Herovici staining (Fig. 5i) but not by qRT–PCR analysis of
several ECM genes (Supplementary Fig. 5j).
To conﬁrm that preconditioning the dermis during develop-
ment was not required to impair EF formation, we also deleted
Smoothened in adult mice via PDGFRa-CreER28 (Supplementary
Fig. 5k, l). 4OHT treatment simultaneously deleted Smoothened
in the dermis (SmoDPdgfra) while activating b-catenin in
the epidermis. This led to inhibition of EF formation and
dermal reprogramming (Fig. 5a–i). In ﬁbroblasts isolated
from SmoDPdgfra skin, expression of Hh target genes was
signiﬁcantly reduced compared with EF ﬁbroblasts with wild-type
Smoothened and comparable to telogen levels (Supplementary
Fig. 5m). In contrast, expression levels of Gli1, Gli2 and Ptch1 in
SmoDDermo/þ ﬁbroblasts were similar to EF ﬁbroblasts
with wild-type Smoothened, consistent with the retention of
one Smoothened allele (Supplementary Fig. 5m). These studies
demonstrate that epidermal b-catenin-mediated EF formation is
dependent on Hh responsiveness of dermal ﬁbroblasts.
Hh and TGF-b inhibition affect distinct ﬁbroblast lineages.
Our data indicate that paracrine Hh signalling primarily
stimulates papillary ﬁbroblast proliferation, which is required for
ectopic HF formation, whereas TGF-b selectively inhibits pro-
liferation of the lower dermal lineage and stimulates adipocyte
differentiation and ECM remodelling. To investigate whether, as
predicted, selective inhibition of Hh in papillary ﬁbroblasts had
the same effect as inhibition in total dermal ﬁbroblasts, we deleted
one Smoothened allele via Blimp1Cre7 and crossed the mice with
K14DNb-cateninER mice (SmoDBlimp1/þ ; Fig. 6a–f). As in the
case of Smoothened deletion via Dermo1Cre or PDGFRa-CreER,
SmoDBlimp1/þ skin harboured fewer ﬁbroblasts in the papillary
and reticular dermis and dermal sheath on epidermal b-catenin
activation than controls (Fig. 6a,b and Supplementary Fig. 5n).
SmoDBlimp1/þ skin had a reduced ability to enter anagen or
form EFs and the proportions of Lrig1þ , Sca1þ and Sca1þ /
CD24þ ﬁbroblasts were consistent with telogen (Fig. 5c–f), with
fewer Lrig1þ ﬁbroblasts. Although the number of pre-adipocytes
was not affected by Smo deletion (Fig. 6f), K14DNb-cateninER
SmoDBlimp1/þ skin harboured fewer mature adipocytes
(Fig. 6a,b and Supplementary Fig. 5o), and ECM remodelling
was reduced (Fig. 6b).
To conﬁrm our prediction that TGF-b2 mediates its effects on
the lower dermis, we performed lineage tracing experiments in
combination with RepSox treatment (Fig. 6g–n). We crossed
Lrig1CreER or Dlk1-CreER mice with LSL-tdTomato mice, then
labelled the different lineages by injecting tamoxifen at E16.5
(Fig. 6g,j). When we treated the mice with RepSox at the age of 8
weeks (Fig. 6g–n), we did not detect any difference in the
distribution or abundance of Lrig1þ cells (Fig. 6h,i,o), except for
the appearance of labelled adipocytes (Fig. 6o). However, RepSox
induced proliferation of tdTomato-positive reticular ﬁbroblasts,
which remained largely conﬁned to the lower dermis (Fig. 6k–n),
and led to a substantial increase in tdTomatoþ cells in the
adipocyte layer (Fig. 6p). Thus, our ﬁndings indicate that TGF-b
signalling affects the lower ﬁbroblast lineage.
Differential expression of TGF-b and Hh target genes.
Collectively, our studies show that different ﬁbroblast sub-
populations respond differently to TGF-b and Hh, with papillary,
Lrig1þ , ﬁbroblasts primarily mediating the Hh response and
lower dermal ﬁbroblasts and adipocytes mediating the TGF-b
response. This led us to examine whether different ﬁbroblast
subpopulations differ in expression of Hh and Tgf-b target genes
(Fig. 6q–s). Consistent with our model, Lrig1þ ﬁbroblasts
expressed higher levels of Hh target genes (Fig. 6s). Sca1þ
ﬁbroblasts expressed higher TGF-b target genes such as PDGFb
and Snai2, and lower levels of Id1 and Snai1, which are known to
be downregulated in tumour-promoting conditions29,30 (Fig. 6q).
We also found that TGF-b receptors (TGFBR) were expressed at
higher levels in Lrig1 ﬁbroblasts compared with Lrig1þ cells
in adult telogen skin (Fig. 6r), although in skin with ectopic
follicles there was no difference between Lrig1þ and Lrig1
ﬁbroblasts (Fig. 6r).
qRT–PCR analysis of Hh target gene expression in ﬂow-sorted
PDGFRaH2BeGFPþ /Sca1 or PDGFRaH2BeGFPþ /Sca1þ
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ﬁbroblasts from K14DNb-cateninER skin revealed that after two
doses of 4OHT Hh target genes were elevated to a much greater
extent in Sca1 than Sca1þ ﬁbroblasts (Fig. 6t). Hh target
genes were induced in reticular ﬁbroblasts only after four doses of
4OHT and at a much lower level than in papillary ﬁbroblasts
(Fig. 6t). In contrast, the TGF-b target gene PDGFb was
upregulated maximally after ﬁve doses of 4OHT and to a much
greater extent in Sca1þ than Sca1 ﬁbroblasts (Fig. 6u). The
FGF target gene Sprouty was induced with slower kinetics than
Hh and TGF-b target genes. In addition, it was expressed at
similar levels in Sca1þ and Sca1 ﬁbroblasts (Fig. 6u).
From this analysis, we can conclude that not only are Hh and
TGF-b target genes induced with different kinetics in response to
epidermal b-catenin activation (Fig. 2d), but in addition, the
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NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10537 ARTICLE
NATURE COMMUNICATIONS | 7:10537 | DOI: 10.1038/ncomms10537 | www.nature.com/naturecommunications 9
induction of Hh genes is primarily attributable to Lrig1þ upper
dermal ﬁbroblasts, whereas the TGF-b response is mediated by
Sca1þ lower dermal ﬁbroblasts. As Shh stimulates ﬁbroblast
proliferation, whereas TGF-b does not (Fig. 2), this would
account for the increase in the proportion of papillary ﬁbroblasts
in response to epidermal b-catenin. The stimulation of Sca1þ
ﬁbroblast proliferation is likely attributable, at least in part, to
FGF signalling.
Discussion
We have shown that the remodelling of adult dermis that occurs
in response to sustained epidermal Wnt/b-catenin activation is
mediated by secreted signals with differential effects on different
ﬁbroblast subpopulations. TGF-b signalling acts primarily on the
lower ﬁbroblast lineage, which corresponds to the Dlk1 lineage at
E16.5 and the cells that express Sca1 in adult skin. In contrast,
Shh stimulates proliferation of Sca1-/Lrig1þ ﬁbroblasts, which
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in adult skin are found throughout the papillary and reticular
dermis but are particularly associated with the HFs.
It has recently been demonstrated that ﬁbroblasts originating
from cells that are engrailed-1 (En-1) positive during early
embryogenesis are responsible for the bulk of connective tissue
deposition in dorsal skin31, a function that is attributed to
reticular ﬁbroblasts. These cells are located primarily in the upper
dermis during embryonic development and are scattered
throughout the interfollicular dermis in adult skin. In telogen
skin, these cells, comprising 70% of total ﬁbroblasts, express
CD26, whereas 95% of ﬁbroblasts that are not derived from
En-1þ embryonic cells are CD26 . Our ﬂow cytometric
analysis is consistent with these observations. We found that
70–80% of ﬁbroblasts from adult telogen skin co-expressed Sca1
and CD26 and thus correspond to the En-1þ reticular lineage
(Fig. 4j and Supplementary Fig. 4b), with the remaining cells
being primarily Sca1 Lrig1þ . While Lrig1þ cells were more
widely distributed in the dermis than previously reported, they
were particularly abundant in the dermal sheath, consistent with
their embryonic origin in the papillary dermis.
In the skin, the Hh pathway has long been known to be crucial
for maintaining the epidermal stem cell population, and
regulating the development of HF and sebaceous glands25. Our
studies demonstrate that Hh signalling is also important within
the dermis, particularly within Lrig1þ ﬁbroblasts. This is
consistent with the known role of Hh in controlling the
properties of ﬁbroblasts in various organs. In the gut
epithelium, Hh proteins act as paracrine mitogens to promote
the expansion of adjacent mesenchymal progenitors32, and
paracrine Hh signalling induces renal ﬁbrosis33. Shh can act as
both a short-range, contact-dependent, factor and as a long-
range, diffusible morphogen34,35. LacZ-Reporter assays revealed
Gli1 and Gli2 expression in cells of the upper dermis of telogen
and anagen skin, and also in cells accumulating along anagen
HF36. Furthermore, epidermal Shh has been shown to play a
crucial role in the clustering of mesenchymal cells during HF
development37, and in Shh knock-out mice, dermal condensates
fail to evolve into DP38. This suggests paracrine signalling
between epidermal and mesenchymal cells over a short range, and
underpins our ﬁndings that Hh signalling is more abundant in
ﬁbroblasts with embryonic origin in the papillary dermis.
In ﬁbroblasts, TGF-b is a potent stimulus for migration,
proliferation as well as for the synthesis of ECM proteins and
collagen maturation into a highly cross-linked dense matrix39.
Thus, TGF-b signalling has crucial roles in ﬁbrosis40,41.
Nevertheless, blocking this pathway with RepSox stimulated
proliferation of the reticular ﬁbroblast lineage, and inhibited
ﬁbroblast differentiation into adipocytes. This could be explained
by the fact that epidermal Wnt activation induces expression of
TGF-b2, which has been shown to inhibit ﬁbroblast proliferation
in contrast to TGF-b1 (ref. 15). Furthermore, Repsox appears to
induce ECM synthesis and/or inhibit collagen maturation as we
found increased levels of immature collagens. One paradox that
remains to be explained is why reticular ﬁbroblasts proliferate in
response to epidermal Wnt/b-catenin activation, yet are inhibited
by TGF-b2. This could potentially be due to upregulation of
FGF2, which stimulates ﬁbroblast proliferation and is required for
EF formation. In contrast to TGF-b2, FGF2 inhibits ﬁbroblast
collagen synthesis and downregulates genes involved in ECM
remodelling42. Indirect evidence for a selective effect of FGF2 on
reticular ﬁbroblast proliferation comes from the observation that
FGFR inhibition upregulates Hh target gene expression. It is
also likely that other secreted factors contribute to dermal
remodelling, including Wnt3a and Wnt5a6, and factors that
induce Wnt signalling in the ﬁbroblasts themselves are known
to profoundly alter dermal composition43–45. Furthermore,
adipocyte-derived GFs such as Platelet-derived growth factor
(PDGF), which are known to control epidermal stem cell activity
and regulate HF cycling46, could be involved, because epidermal
Wnt/b-catenin activation affects the composition of the adipocyte
layer, and the block in adipocyte differentiation caused by RepSox
led to an increase in pre-adipocytes.
We have shown that upon epidermal Wnt activation Hh
signalling is activated early in ﬁbroblasts, whereas TGF-bR and
FGFR pathways are induced later. This is in accordance with a
delayed expression of TGF-b2 and FGF2 by epidermal cells, but
could also be due to cross-talk between the papillary and reticular
ﬁbroblast lineages. Although it has been reported that active
TGF-b signalling induces the Hh pathway47, our data suggest that
Hh signalling is not affected in skin when mice are treated
with a TGF-bR inhibitor, and vice versa. Nevertheless, when Hh
signalling is inhibited, the lower dermis does not respond to
epidermal b-catenin activation, suggesting that there is inter-
dependence within the lineages, and a possible cross-talk between
ﬁbroblast subpopulations. Whether this is promoted by
intermixing ﬁbroblast populations due to epidermal b-catenin-
mediated anagen induction remains to be explored.
The fact that epidermal Wnt activation triggers distinct
signalling pathways in different ﬁbroblast lineages is interesting
in light of the well-established role of Wnt in different types of
cancer including those of HFs. Shh has been shown to play a role
in tumour stroma48, and interestingly depletion of ﬁbroblasts can
exacerbate tumour growth49,50, indicating that not all cancer
stroma is tumour supportive. More focus should be placed on the
roles of distinct ﬁbroblast lineages in cancer development and
progression, and possibly other diseases.
Methods
Mice. All animal procedures were subject to local institutional ethical approval and
performed under a UK Government Home Ofﬁce license. K14DNb-cateninER2,
Figure 6 | Epidermal b-catenin activation induces Hh and TGF-b signalling in distinct ﬁbroblast lineages (a,b) Immunolabelling (a) and Herovici staining
(b) of skin from K14DNb-cateninER mice in telogen, following 4OHT treatment to induce ectopic hair follicles (EFs) or in combination with heterozygous
Smoothened deletion via Blimp1Cre (SmoDBlimp1/þ ). Scale bars, 200mm. (c) Representative ﬂow cytometry plots of Sca1þ and Lrig1þ ﬁbroblasts after
gating on PDGFRaH2BeGFPþ cells. (d–f) Summary of ﬂow cytometric analysis. Data represent mean±s.e.m. (n¼ 3). *,#Pr0.05; ***,###Pr0.0005 by a
one-way analysis of variance, compared with telogen or EF skin, respectively. (g–i) Labelling Lrig1þ cells. (g) Experimental strategy; (h,i) skin sections from
adult mice treated with vehicle (h) or RepSox (i). Insets are higher magniﬁcation images. (j–n) Labelling Dlk1þ cells. (j) Experimental strategy; (k–n) skin
sections from adult mice treated with vehicle (k,m) or RepSox (l,n). (m,n) Grey scale images with higher magniﬁcation of the red channel in e,f,
respectively. AD, adipocyte layer; PC, panniculus carnosus. Dotted lines denote thickness of adipocyte layer. Scale bars, 200 mm. (o,p) Quantiﬁcation of
tdTomatoþ cells within the interfollicular dermis (IFD) and AD of skin treated with RepSox or vehicle in Lrig1CreER (o) or Dlk1CreER (p) transgenic mice
shown in g–n. Data represent mean±s.e.m. (n¼ 3; 3 ﬁelds quantiﬁed per biological sample). *Pr0.05, ***Pr0.0005 by Student’s t-test. (q–s) Relative
expression of TGF-b (q) and Hh target genes (s) and TGF-b receptors (TGFBR; r) in Sca1 and Sca1þ (q) or Lrig1þ and Lrig1 (r,s) ﬁbroblasts in adult
dermis. Data represent mean±s.e.m. (n¼ 3–4). Data were normalized to Sca1 or Lrig1þ cells in telogen. *Pr0.05, **Pr0.005 by Student’s t-test. (t,u)
Relative expression of Hh target genes (t) and TGF-b and FGF target genes (u) in Sca1þ and Sca1 ﬁbroblasts isolated from K14DNb-cateninER/
PDGFRaH2BeGFP double transgenic mice treated with 4OHT once or up to seven times. Data represent mean±s.e.m. (n¼ 2; pooled from 3 to 5 mice).
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Lrig1-GFP-IRES-CreER20 (Lrig1CreER) and Dlk1-CreERt7 (Dlk1CreER), and
Pdgfra-CreER28 transgenic mice were generated previously. Conditional
Smoothened (Smotm2Amc/J)26, Dermo1Cre (B6.129X1-Twist2tm1.1(cre)Dor/J)27,
Blimp1-Cre51, PdgfraH2BeGFP52 and ROSA26-tdTomato21 mice were purchased
from the Jackson Laboratory. Three micrograms of 4OHT (Sigma-Aldrich) in
200ml of acetone (vehicle) was administered topically to the back skin of adult mice
to activate the K14DNb-cateninER transgene or to delete Smoothened. When mice
received more than one dose of 4OHT, the doses were applied every second day.
Telogen samples were obtained from wild-type mice that had received the same
number of 4OHT treatments as the corresponding K14DNb-cateninER2 in each
experiment. For the lineage tracing experiments, Lrig1CreER or Dlk1CreER
transgenic pregnant females received a dose of 25 or 75 mg per g mouse of
tamoxifen (Sigma-Aldrich) intraperitoneally, respectively. In some experiments,
mice received a dose of 500mg EdU (Invitrogen) dissolved in PBS intraperitoneally
3–6 h before tissues were harvested.
Mice received a dose of 1 mmol RepSox (Tocris) or 25mg per kg body
weight PD173074 dissolved in acetone (Tocris) or vehicle only topically onto
the back skin. Experiments involving IPI4182 (compound 32)16 were performed
at the Cancer Research Institute Cambridge, Cancer Research UK (CRUK).
A 10mgml 1 IPI4182 stock solution was prepared in 10% (2-hydroxylpropyl)-
b-cyclodextrin/0.1M sodium citrate/phosphate, pH3 (vehicle) and administered by
oral gavage at a dose of 60mg per kg body weight per day.
No statistical methods (power calculations) were used to predetermine sample
size. However, based on prior experience with the experimental models, the
experiments were designed to use the smallest number of mice predicted to
generate statistically meaningful data. Experiments were performed on 6- to
8-week-old sex-matched mice. Experiments were performed on male and female
animals. After genotyping, mice were assigned randomly to treatment groups.
Because of the severe skin phenotype of K14DNb-cateninER2 mice treated
repeatedly with 4OHT, blinded assessment of experimental outcomes was not
always applicable; however, it was used whenever possible. Mice were excluded
from analysis only if they had to be euthanized because of health concerns.
Histology and microscopy. Parafﬁn- or optimal cutting temperature compound-
embedded tissues were sectioned and stained6,7 using the following primary
antibodies (all diluted 1:100 unless stated otherwise) for immunoﬂuorescence
labelling: Lrig: R&D Systems, FAB3688G; CD26: R&D Systems, AF954; Sca1: R&D
Systems, AF1226; PDGFRa: R&D Systems, AF1062; Collagen III: Abcam, ab7778,
Collagen11a1: Abcam, ab64883; Elastin: Abcam, ab21610; Caveolin: Cell Signaling
Technology, 3267; phospho-Histone H3 (Ser10) antibody: Cell Signalling
Technology, 970; Active Caspase-3: RnD Systems, AF835; K14: Covance, PRB-
155P, 1:500; GFP: Abcam, ab13970, 1:500; RFP: Rockland, 600-401-379, 1:300.
EdU staining was performed with a Click-it EdU imaging kit (Invitrogen)
according to the manufacturer’s recommendations. Images were acquired with a
Nikon A1 Upright Confocal microscope. Images of H&E- and Herovici-stained
sections were acquired with a Hamamatsu slide scanner. Representative images of
skin from two to three independent experiments with at least three biological
replicates per group are shown.
Flow cytometry and cell sorting. Dermal cells for ﬂuorescence-activated
cytometric cell sorting and analysis6,7 were labelled according to standard
procedures with the following antibodies: anti-ITGA6-APC (AbSource, 1:20),
Lrig1-PE (RnD systems, 1:20), anti-CD24-PE clone: M1/69 (BioLegend, 1:100),
anti-Ly-6A/E (Sca1)-BV605 (BD Horizon, 1:200) or Alexa Fluor 700,
anti-CD26-APC and anti-CD140a-PE or APC (eBioscience, 1:20). Click-it EdU
Flow Cytometry Assay Kits (Invitrogen) were used to detect proliferating cells.
Labelled cells were analysed on a BD LSRFortessa cell analyser. 4,6-Diamidino-2-
phenylindole or LIVE/DEAD Fixable Violet Dead Cell Stain (Life Technologies)
was used to exclude dead cells.
Cell culture. Mouse primary ﬁbroblasts were isolated6 and cultured in DMEM
supplemented with 10% FCS or Amniomax (Gibco). Cells were pulsed with 10 mM
EdU 3–4 h before ﬁxation and staining with the Click-it EdU Imaging Kit
(Invitrogen). To stimulate or inhibit speciﬁc signalling pathways in ﬁbroblasts, the
following concentrations of GFs and inhibitors were added to the medium for 24 or
48 h: Shh 1 mgml 1; TGF-b2 10 ngml 1; FGF2 20 ngml 1; FGF5 10 ngml 1
(all from RnD Systems; vehicle: PBS); IPI4182 0.5 mM (Inﬁnity Pharmaceuticals;
vehicle: DMSO); RepSox 25mM (Tocris; vehicle: DMSO); PD173074 2 mM (Tocris;
vehicle: DMSO). DED was prepared by ﬂoating 5mm diameter punch biopsies of
back skin on 0.8% trypsin (Gibco) dissolved in PBS for 60min, separating the
dermis from the epidermis with forceps and depleting cells from the tissue by at
least ten freeze–thaw cycles. Before ﬁbroblasts were seeded onto DEDs, the tissue
was placed into 24-well cell culture inserts and equilibrated with medium.
qRT–PCR. Total RNA was puriﬁed with the Purelink RNA micro kit (Invitrogen)
with on-column DNaseI digestion, according to the manufacturer’s instructions.
RNA was reverse transcribed with SuperScriptIII (Invitrogen). PCR reactions were
performed with TaqMan Fast Universal PCR Master Mix and Taqman probes
purchased from Invitrogen.
Graphing and statistical analysis. All graphs were generated using Excel and
GraphPad Prism 6 software. Data are means±standard error of the mean (s.e.m.).
One-way analysis of variance parametric test with Bonferroni Post-Test or
Student’s t-tests were performed for experiments, with Po0.05 considered
signiﬁcant.
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